Proficio Capital Partners LLC Invests $283,000 in National Research Co. (NASDAQ:NRC)

Proficio Capital Partners LLC bought a new stake in National Research Co. (NASDAQ:NRC) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 16,035 shares of the company’s stock, valued at approximately $283,000. Proficio Capital Partners LLC owned approximately 0.07% of National Research as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. Bank of New York Mellon Corp raised its position in National Research by 88.5% during the 4th quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company’s stock worth $3,832,000 after purchasing an additional 101,957 shares during the last quarter. Principal Financial Group Inc. boosted its stake in National Research by 10.7% during the 4th quarter. Principal Financial Group Inc. now owns 12,018 shares of the company’s stock valued at $212,000 after purchasing an additional 1,161 shares during the last quarter. Exchange Traded Concepts LLC boosted its stake in shares of National Research by 17.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 16,421 shares of the company’s stock worth $290,000 after buying an additional 2,412 shares during the last quarter. Inspire Investing LLC boosted its stake in shares of National Research by 26.1% in the 4th quarter. Inspire Investing LLC now owns 22,952 shares of the company’s stock worth $405,000 after buying an additional 4,746 shares during the last quarter. Finally, SG Americas Securities LLC boosted its stake in shares of National Research by 35.0% in the 4th quarter. SG Americas Securities LLC now owns 7,298 shares of the company’s stock worth $129,000 after buying an additional 1,893 shares during the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Trading Down 2.0 %

NASDAQ:NRC opened at $14.89 on Wednesday. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. The stock has a market capitalization of $349.56 million, a PE ratio of 14.18 and a beta of 0.47. The firm’s 50 day moving average is $16.62 and its 200 day moving average is $18.70. National Research Co. has a 12 month low of $13.74 and a 12 month high of $40.69.

National Research (NASDAQ:NRC) last issued its earnings results on Monday, January 27th. The company reported $0.28 earnings per share (EPS) for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.